间质性肺异常的发病率:MESA肺研究
ILA和纤维化ILA的发病率分别为13.1和3.5例/1000人年;年龄、基线高衰减区、MUC5B启动子单核苷酸多态性与两者相关,而曾吸烟和特发性肺纤维化多基因风险评分仅与纤维化ILA相关。
要点
- ILA和纤维化ILA的发病率分别为13.1和3.5例/1000人年
- MUC5B启动子SNP与ILA(HR 1.73)和纤维化ILA(HR 4.96)均相关
- 曾吸烟和IPF多基因风险评分仅与纤维化ILA相关
核心结论
- 通过心脏影像学评估可估算新发ILA和纤维化ILA的发病率。
- 这些发现可能促进将动脉粥样硬化筛查工具用于识别临床前肺部疾病。
研究设计与样本
- 多民族动脉粥样硬化研究(MESA)纵向队列研究,纳入6197名45岁以上参与者。
- 排除基线时存在ILA的参与者后计算发病率及发病率比。
- 5%的扫描由同一或不同观察者以盲法重读。
主要发现
- ILA的读者内一致性为92.0%(Gwet's AC1 0.912,ICC 0.982),读者间一致性为83.5%(Gwet's AC1 0.814,ICC 0.969)。
- ILA和纤维化ILA的估计发病率分别为13.1和3.5例/1000人年。
- 年龄与ILA(HR 1.06,95%CI 1.05-1.08,p<0.001)和纤维化ILA(HR 1.08,95%CI 1.06-1.11,p<0.001)相关。
- 基线高衰减区与ILA(HR 1.05,95%CI 1.03-1.07,p<0.001)和纤维化ILA(HR 1.06,95%CI 1.02-1.10,p=0.002)相关。
- MUC5B启动子SNP与ILA(HR 1.73,95%CI 1.17-2.56,p=0.01)和纤维化ILA(HR 4.96,95%CI 2.68-9.15,p<0.001)相关;曾吸烟(HR 2.31,95%CI 1.34-3.96,p=0.002)和IPF多基因风险评分(HR 2.09,95%CI 1.61-2.71,p<0.001)仅与纤维化ILA相关。
临床怎么用
- 心脏CT扫描可用于机会性筛查临床前间质性肺异常。
- 对年龄较大、有吸烟史或高衰减区者应关注ILA风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidence of newly developed interstitial lung abnormalities (ILA) and fibrotic ILA has not been previously reported. METHODS: Trained thoracic radiologists evaluated 13 944 cardiac computed tomography scans for the presence of ILA in 6197 Multi-Ethnic Study of Atherosclerosis (MESA) longitudinal cohort study participants >45 years of age from 2000 to 2012. Five percent of the scans were re-read by the same or a different observer in a blinded fashion. After exclusion of participants with ILA at baseline, incidence rates and incidence rate ratios for ILA and fibrotic ILA were calculated. RESULTS: The intra-reader agreement of ILA was 92.0% (Gwet's AC1 0.912, intraclass correlation coefficient (ICC) 0.982) and the inter-reader agreement of ILA was 83.5% (Gwet's AC1 0.814, ICC 0.969). Incidence of ILA and fibrotic ILA was estimated to be 13.1 and 3.5 cases per 1000 person-years, respectively. In multivariable analyses, age (hazard ratio (HR) 1.06 (95% CI 1.05-1.08); p<0.001 and HR 1.08 (95% CI 1.06-1.11); p<0.001), high attenuation area at baseline (HR 1.05 (95% CI 1.03-1.07); p<0.001 and HR 1.06 (95% CI 1.02-1.10); p=0.002) and the MUC5B promoter single nucleotide polymorphism (HR 1.73 (95% CI 1.17-2.56); p=0.01 and HR 4.96 (95% CI 2.68-9.15); p<0.001) were associated with incident ILA and fibrotic ILA, respectively. Ever-smoking (HR 2.31 (95% CI 1.34-3.96); p=0.002) and an idiopathic pulmonary fibrosis polygenic risk score (HR 2.09 (95% CI 1.61-2.71); p<0.001) were associated only with incident fibrotic ILA. CONCLUSIONS: Incident ILA and fibrotic ILA were estimated by review of cardiac imaging studies. These findings may lead to wider application of a screening tool for atherosclerosis to identify pre-clinical lung disease.
引用
- McGroder CF, Hansen S, Hinckley Stukovsky K, et al. Incidence of interstitial lung abnormalities: the MESA Lung Study. Eur Respir J. 2023. PMID: 37202153. doi:10.1183/13993003.01950-2022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。